![]() |
市場調査レポート
商品コード
1801223
ラボ用ろ過の市場規模、シェア、動向、予測:製品タイプ、技術、エンドユーザー、地域別、2025~2033年Laboratory Filtration Market Size, Share, Trends and Forecast by Product Type, Technique, End User, and Region, 2025-2033 |
||||||
カスタマイズ可能
|
ラボ用ろ過の市場規模、シェア、動向、予測:製品タイプ、技術、エンドユーザー、地域別、2025~2033年 |
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 118 Pages
納期: 2~3営業日
|
ラボ用ろ過の世界市場規模は2024年に44億1,000万米ドルとなりました。今後、IMARC Groupは、同市場が2033年までに80億9,000万米ドルに達し、2025~2033年にかけて6.63%のCAGRを示すと予測しています。現在市場を独占しているのは北米ので、2024年には47.09%以上の市場シェアを占めます。北米の地域の成長の原動力は、バイオ医薬品生産の増加、厳しい規制要件、ラボにおける革新的なろ過技術の採用率の高さです。同地域のラボ用ろ過市場シェアの増加はさらに、ライフサイエンス研究への旺盛な投資と、産業全体にわたる高純度ろ過ソリューションへの需要の高まりに起因しています。
製薬会社やバイオテクノロジー企業は研究開発(R&D)に多額の資金を投じており、実験や手順の純度と信頼性を確保するために一流のろ過システムが必要とされています。さらに、モノクローナル抗体、ワクチン、細胞療法などの生物製剤の製造が増加しており、無菌状態を維持し汚染を避けるために先進的ろ過技術が必要とされていることも、市場に明るい展望をもたらしています。加えて、規制機関は医薬品や生物製剤の製造に厳しい規制を導入しており、その結果、このような高い基準を遵守できるろ過システムへの需要が高まっています。これとは別に、技術の進歩により、粒子や微生物の分離を強化できる、より効果的で正確なろ過システムの構築が推進されています。さらに、利便性、汚染リスクの低減、洗浄費用の削減で知られるシングルユースシステムの採用が増加していることも、ラボや生産施設での市場拡大を後押ししています。
米国は、ラボ用ろ過システムに対するニーズを大いに煽る強力な製薬とバイオテクノロジー産業によって推進されている、この市場にとって不可欠な地域です。これらのセグメントでは、医薬品開発、製造、品質保証の各段階において、無菌性、純度、規制遵守を確保するために、最先端のろ過技術に大きく依存しています。IMARC Groupによると、米国のバイオテクノロジー市場は、2024~2032年の間にCAGR9.50%を記録すると予測されています。また、革新的な医薬品や治療法の研究プログラムに国が多額の投資を行っているため、正確で信頼性の高いろ過システムが必要とされています。ろ過は、実験の完全性の維持、サンプル調製、プロセスのスケールアップに不可欠であり、製薬バイオテクノロジーセグメントのイノベーションを促進します。
研究開発活動の活発化
研究開発活動の活発化により、新薬、治療、ワクチンの需要が高まっており、バイオテクノロジーや製薬産業の成長に寄与しています。そこで必要とされるのが、ラボ用ろ過製品です。これらは、生物製剤、テーラーメイド療法、ワクチンの創製に必要な研究活動において、無菌性、精度、信頼性を維持するために必要とされます。報告によると、2020年、スペインの大学・専門学校はバイオテクノロジー関連の研究開発に約4億7,760万ユーロを割り当て、これは2009年以降で最高額となりました。分析期間中、大学のバイオテクノロジー研究開発費は約50%増加しました。さらに、高度ろ過技術への投資の増加、バイオ医薬品パイプラインの範囲拡大、医薬品やワクチンの開発に対する厳しい規制要件が、市場の成長をさらに後押ししています。
慢性疾患の増加
慢性疾患の増加と高齢化は、ラボ用ろ過市場の拡大に寄与する主要因です。National Center for Chronic Disease Prevention and Health Promotionの記事によると、米国では約1億2,900万人が心臓病、がん、糖尿病、肥満、高血圧などの重大な慢性疾患を少なくとも1つは抱えていると推定されています。このような状況下では、定期的な診断検査とモニタリングが必要となり、正確な結果を得るために高い精度と信頼性でサンプルを調製するろ過システムが必要となります。さらに、高齢者の増加により慢性疾患の罹患率が高まり、先進的ヘルスケアオプションの必要性が高まっています。診断精度を高め、厳格なヘルスケア基準を遵守するために、先進的ろ過技術が利用されています。これらの要因は、ラボ用ろ過市場予測にさらにプラスの影響を与えています。
技術の進歩
検査室に自動化システムやロボット工学を取り入れることで、精度が向上し、人的ミスが最小限に抑えられ、効率が高まるため、検査室のプロセスに革命が起きています。自動ろ過システムは、膨大な量のサンプルを確実な精度で処理できるため、バイオ医薬品、化学工学、材料科学など、さまざまなセグメントの研究開発プロセスを大幅にスピードアップすることができます。例えば、2023年12月、ABBロボティクスはXtalPiと協働して、バイオ医薬品、化学工学、新エネルギー材料の研究開発効率を高めるために設計された自動ラボワークステーションを中国で開発しました。これらの進歩は、厳しい規制要件の遵守を保証しながら、手作業と運用経費を最小限に抑えます。自動ろ過システムは大量のサンプルを処理できるため、ラボの研究開発プロセスをスピードアップし、ラボ用ろ過市場の収益を押し上げます。
The global laboratory filtration market size was valued at USD 4.41 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 8.09 Billion by 2033, exhibiting a CAGR of 6.63% from 2025-2033. North America currently dominates the market, holding a market share of over 47.09% in 2024. The growth of the North American region is driven by increasing biopharmaceutical production, strict regulatory requirements, and high adoption of innovative filtration technologies in laboratories. The region's increasing laboratory filtration market share is further attributed to robust investments in life sciences research and the rising demand for high-purity filtration solutions across industries.
Pharmaceutical and biotechnology firms are dedicating significant funds to research and development (R&D), necessitating top-notch filtration systems to ensure the purity and dependability of experiments and procedures. Moreover, the increasing manufacturing of biologics such as monoclonal antibodies, vaccines, and cell therapies, necessitating sophisticated filtration technologies to maintain sterility and avoid contamination, is presenting a positive market perspective. In addition, regulatory agencies are implementing stringent regulations for the production of drugs and biologics, resulting in an increased demand for filtration systems that can adhere to these elevated standards. Apart from this, advancements in technology are driving the creation of more effective and accurate filtration systems, allowing for enhanced separation of particles and microorganisms. Furthermore, the increasing adoption of single-use systems, known for their convenience, lower contamination risks, and reduced cleaning expenses, is driving the market expansion in laboratories and production facilities.
The United States is an essential part of the market, propelled by a strong pharmaceutical and biotechnology industry that greatly fuels the need for laboratory filtration systems. These sectors depend significantly on cutting-edge filtration technologies to ensure sterility, purity, and adherence to regulations throughout drug development, production, and quality assurance stages. According to the IMARC Group, the biotechnology market in the US is projected to have a compound annual growth rate (CAGR) of 9.50% between 2024 and 2032. In addition, significant investments made by the country in research programs for innovative medications and treatments require accurate and dependable filtration systems. Filtration is crucial for maintaining the integrity of experiments, preparing samples, and scaling up processes, fostering innovation in the pharmaceutical and biotechnology sectors.
Rising R&D Activities
The demand for new drugs, therapies, and vaccines is rising because of the increase in research and development efforts, which is contributing to growth within the biotechnology and pharmaceutical industries. The items required include laboratory filtration products. These are required to maintain sterility, precision, and dependability in research activities that are necessary to create biologics, tailored therapies, and vaccines. According to reports, in 2020, universities and colleges in Spain allocated about 477.6 million euros for biotechnology-associated research and development, which was the highest amount since 2009. During the period of analysis, universities increased their biotech R&D expenditures by about 50%. Additionally, growing investments in advanced filtration technologies, an expanding scope of biopharmaceutical pipelines, and stringent regulatory requirements for the development of drugs and vaccines further fuel the market growth.
Growing Prevalence of Chronic Diseases
The rise in chronic illnesses and the aging demographic are major factors contributing to the expansion of the laboratory filtration market. An article from the National Center for Chronic Disease Prevention and Health Promotion estimates that around 129 million individuals in the United States have at least one significant chronic condition, such as heart disease, cancer, diabetes, obesity, and hypertension. These circumstances demand regular diagnostic testing and oversight, calling for filtration systems to prepare samples with great accuracy and dependability for precise outcomes. Moreover, the elderly population leads to a greater incidence of chronic illnesses, which escalates the need for sophisticated healthcare options. The utilization of advanced filtration technologies to enhance diagnostic precision and adhere to strict healthcare standards. These factors are further positively influencing the laboratory filtration market forecast.
Technological Advancements
The incorporation of automated systems and robotics in laboratories is improving accuracy, minimizing human mistakes, and boosting efficiency, thus revolutionizing laboratory processes. Automated filtration systems are capable of processing vast amounts of samples with reliable precision, greatly speeding up the research and development process in multiple areas, such as biopharmaceuticals, chemical engineering, and materials science. For example, in December 2023, ABB Robotics collaborated with XtalPi to create automated lab workstations in China, designed to enhance R&D efficiency in biopharmaceuticals, chemical engineering, and new energy materials. These advancements minimize manual work and operational expenses while guaranteeing adherence to stringent regulatory requirements. Automated filtration systems can handle a large volume of samples, thus speeding up the research and development process in laboratories and boosting the laboratory filtration market revenue.
Filtration media stands as the largest component in 2024, holding 53.5% of the market share. As per the laboratory filtration market forecast, filtration media refer to materials employed in filtration methods to eliminate particles, pollutants, and impurities from fluids (liquids or gases). These media are designed to permit the fluid to flow while efficiently capturing or eliminating undesirable materials, guaranteeing the intended purity level. They are essential in numerous applications, such as drug discovery, biotechnology, and environmental testing, where accuracy and cleanliness are crucial. The increasing investment in research and development for drug discovery and creation requires high-quality filtration media to guarantee purity, precision, and consistency in experiments, thus boosting demand. Filtration media like membrane filters, depth filters, and activated carbon filters are designed for particular uses, increasing their effectiveness. The increasing occurrence of chronic illnesses and the corresponding advancement of biologics, vaccines, and tailor-made medications also drive the need for sophisticated filtration materials. Moreover, strict regulatory standards and the growing emphasis on sustainability are driving advancements in eco-friendly and reusable filtration materials.
Microfiltration leads the market with 36.5% of the market share in 2024. According to the laboratory filtration market overview, microfiltration (MF) is a widely used technique essential for separating particles and microorganisms from fluids. It employs membrane filters with pore sizes typically ranging from 0.1 to 10 micrometers, making it particularly effective for removing bacteria, suspended solids, and larger particles. High purity and sterility are critical for producing drugs, biologics, and vaccines, driving the need for microfiltration to eliminate microorganisms and particulates. This technique is indispensable in biopharmaceutical manufacturing, where contamination-free processes are paramount. MF is also widely applied in sample preparation, effectively removing particulates that could interfere with analytical techniques such as chromatography and spectroscopy, ensuring accurate and reliable results. Additionally, microfiltration is employed in environmental testing, food and beverage processing, and water purification, emphasizing its versatility. The growing adoption of disposable filtration systems in laboratories and increasing regulatory requirements for sterility further enhance the demand for MF in various industries.
Pharmaceutical and biopharmaceutical companies lead the market because of their significant utilization of filtration technologies in drug creation, manufacturing, and quality control procedures. These businesses depend on sophisticated filtration systems to guarantee the purity and effectiveness of their products, adhere to strict regulatory standards, and uphold contamination-free settings. The expanding portfolio of biologics, vaccines, and personalized medicines enhances the need for filtration solutions, especially for sterile filtration, virus filtration, and ultrafiltration uses. Biopharmaceutical companies, specifically, gain advantages from filtration systems with high capacity designed for the manufacturing of monoclonal antibodies, recombinant proteins, and cell and gene therapies. Moreover, the rising incidence of chronic illnesses and the worldwide focus on drug development stimulate investments in advanced filtration technologies. Partnerships between filtration system suppliers and pharmaceutical companies to create tailored, effective solutions further strengthen this supremacy. This trend is supported by the increasing emphasis on sustainability, encouraging reusable and energy-saving filtration systems.
In 2024, North America accounted for the largest market share of 47.09%. According to the laboratory filtration market statistics, the well-established pharmaceutical and biopharmaceutical manufacturing industries in North America drive the need for advanced laboratory filtration to ensure product quality and strict compliance with the regulatory environment. Meanwhile, intense R&D activities in these industries require highly reliable filtration equipment for sample preparation, purification, and analysis. Moreover, nanofiltration and ultrafiltration among other developments in membrane technology enhance the performance and effectiveness of laboratory filtration equipment. In addition, the introduction of novel membrane filter products and related filtration systems is expected to drive regional market growth through the forecast period. For example, in November 2021, DuPont Water Solutions (DWS) launched the TapTec LC HF-4040 reverse osmosis membrane filter, which offers high flow rates while remaining dependable.
United States Laboratory Filtration Market Analysis
In North America, the United States is a crucial segment, holding 86.70% market share in 2024. Laboratory filtration in the United States has been gaining pace primarily because of an increase in healthcare sector investment, which has significantly risen in recent times. According to JP Morgan, Seed and Series A funding into U.S. biopharma companies totaled USD 5.1 Billion across 105 rounds in the first half of 2024. With an expanding focus on healthcare infrastructure, there has been a surge in the demand for advanced filtration technologies that ensure the purification of water, chemicals, and biological samples, thus supporting research and diagnostics. This investment in healthcare also fuels the growth of better filtration solutions in response to the changing needs of laboratories to maintain precision and safety. In addition, the tighter the regulatory measures are, the more dependent laboratories become on filtration systems when meeting safety and quality standards. This combination of increased funding and the need for cutting-edge filtration solutions is propelling the widespread adoption of laboratory filtration across various medical and research fields.
Europe Laboratory Filtration Market Analysis
In Europe, increased chronic diseases and an aging population have further increased the demand for efficient laboratory filtration systems. For instance, the elderly population is growing in Europe, with one in every five Europeans aged 65 years or older estimated to reach nearly 30% by 2050. With the population aging, there is a resulting rising need for diagnostic tests and therapies concerning chronic illnesses like heart disease, diabetes, and respiratory disorders. It is against this demographic change that laboratories are investing in state-of-the-art filtration technologies that upgrade accurate procedures for diagnoses and protect the patient's safety. More and more laboratories are conducting complex research and clinical studies, hence increasing the demand for superior filtration systems. The growing interest in public health and the prevention of diseases has made healthcare providers take on the implementation of advanced technologies that enhance the quality of life of the elderly. Laboratory filtration systems are also very important in ensuring that tests, samples, and medical devices are safeguarded and comply strictly with health and safety regulations.
Asia Pacific Laboratory Filtration Market Analysis
In the Asia-Pacific area, the increasing focus on healthcare improvements has notably enhanced the use of laboratory filtration technologies. The Ministry of Commerce and Industry, India, reports that there are 1162 investment projects totaling USD 31.47 Billion in the healthcare sector throughout various states in India. The growing emphasis on advancing healthcare infrastructure and medical research skills has driven the need for filtration systems that improve research results, diagnostics, and safety for patients. Improvements in medical device technology, along with increasing healthcare costs, are prompting labs to adopt filtration systems that provide cleaner and safer workspaces. These advancements enable laboratories to attain improved accuracy in tests and experiments, especially in crucial areas such as pharmaceuticals and diagnostics. Furthermore, the healthcare industry's dedication to adopting advanced technologies to address new diseases and enhance public health has laid a robust groundwork for the ongoing use of filtration systems.
Latin America Laboratory Filtration Market Analysis
The expansion of the private healthcare system in Latin America has played a crucial role in the increasing use of laboratory filtration technologies. As per the International Trade Administration, Brazil boasts the largest healthcare market in Latin America, featuring 7,191 hospitals, with 62% being private institutions. With the ongoing growth of the private healthcare industry, there is increasing focus on upholding excellent standards in medical testing and diagnostics. This has resulted in a greater demand for trustworthy filtration systems to guarantee the cleanliness of samples and materials utilized in medical procedures. Laboratories in the area are putting resources into sophisticated filtration technologies to meet the need for precise and reliable diagnostic outcomes. Moreover, private healthcare organizations seek to provide competitive services, necessitating their adoption of the newest technologies in medical testing, such as filtration systems. The growing presence of private healthcare institutions is leading to an escalating need for efficient laboratory filtration systems.
Middle East and Africa Laboratory Filtration Market Analysis
The growth of hospitals and diagnostic laboratories in the Middle East and Africa has driven the demand for laboratory filtration systems. According to Dubai Healthcare City Authority report, Dubai's healthcare sector saw rapid growth, with 4,482 private medical facilities and 55,208 licensed professionals by 2022, projected to expand further by 3-6% in facilities and 10-15% in professionals in 2023. With an expanding healthcare infrastructure, there is a growing need for high-quality filtration technologies to ensure the purity of samples and testing environments. Laboratories in the region are increasingly adopting filtration solutions to meet the rising standards of diagnostic accuracy and safety. Additionally, with the ongoing development of healthcare services to meet the needs of a growing and diverse population, filtration systems are becoming an integral part of laboratory setups. This shift is essential for ensuring the reliability of tests, improving healthcare outcomes, and complying with international standards for medical research and patient care. The rise of medical facilities is thus pushing the adoption of advanced filtration solutions across the region.
Major participants in the market are concentrating on strategic actions to enhance their market standing and address changing industry needs. This entails developing advanced filtration techniques to enhance efficiency, precision, and scalability in various applications. Companies are making substantial investments in research efforts to create advanced filtration systems tailored to pharmaceutical, biotechnology, and industrial needs. Through broadening their range of products and establishing partnerships or purchasing other firms, they can expand their market reach and grow their user base. Major companies are highlighting sustainable practices by providing reusable and environment-friendly filtration products to tackle ecological issues. In 2024, Sartorius introduced the Vivaflow(R) SU, an advanced tangential flow filtration (TFF) cassette aimed at research scientists. This disposable, integrated cassette simplifies usability, optimizes ultrafiltration procedures, and boosts sustainability by cutting plastic usage by 30.5%. It streamlines molecule concentration and rebuffering, removing complicated calculations and reducing waste.